Related references
Note: Only part of the references are listed.Replicatively senescent cells are arrested in G1 and G2 phases
Zhiyong Mao et al.
Aging-US (2016)
Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues
EA Georgakopoulou et al.
Aging-US (2016)
Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells
Weibo Luo et al.
Oncotarget (2015)
Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer
Lydia Kriegl et al.
Oncotarget (2015)
MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways
Zhaoyong Hu et al.
AGING-US (2014)
Cellular senescence and its effector programs
Rafik Salama et al.
GENES & DEVELOPMENT (2014)
Geriatric muscle stem cells switch reversible quiescence into senescence
Pedro Sousa-Victor et al.
NATURE (2014)
The role of senescent cells in ageing
Jan M. van Deursen
NATURE (2014)
Cellular senescence: from physiology to pathology
Daniel Munoz-Espin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
In Vivo and In Vitro Analysis of Age-Associated Changes and Somatic Cellular Senescence in Renal Epithelial Cells
Birgit Berkenkamp et al.
PLOS ONE (2014)
Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
Olga V. Leontieva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence
Yi Luo et al.
TRANSPLANTATION (2014)
Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved
Maria Grazia Vizioli et al.
ONCOTARGET (2014)
Caspase-2 regulates oncogene-induced senescence
Delphine Gitenay et al.
ONCOTARGET (2014)
Berberine suppresses gero-conversion from cell cycle arrest to senescence
Hong Zhao et al.
AGING-US (2013)
Human nevi lack distinguishing senescence traits
Sieu Tran et al.
AGING-US (2013)
How to measure RNA expression in rare senescent cells expressing any specific protein such as p16Ink4a
Jessie C. Jeyapalan et al.
AGING-US (2013)
Genetics of Longevity in Model Organisms: Debates and Paradigm Shifts
David Gems et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction?
David Gems et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Dysregulation of the mTOR pathway in p53-deficient mice
Olga V. Leontieva et al.
CANCER BIOLOGY & THERAPY (2013)
Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
Christin E. Burd et al.
CELL (2013)
mTOR in aging, metabolism, and cancer
Marion Cornu et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression
Xing-mei Zhang et al.
GENE (2013)
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tamara Tchkonia et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta et al.
NATURE CELL BIOLOGY (2013)
TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists
M. V. Blagosklonny
CELL DEATH & DISEASE (2013)
Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine
Kyung H. Yi et al.
ONCOTARGET (2013)
Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer
Leigh Ellis et al.
ONCOTARGET (2013)
Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy
Frank Louwen et al.
ONCOTARGET (2013)
FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies
Rocky Cipriano et al.
ONCOTARGET (2013)
LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program
Xing-gang Mao et al.
ONCOTARGET (2013)
A senescent cell bystander effect: senescence-induced senescence
Glyn Nelson et al.
AGING CELL (2012)
Tumor suppression by p53 without apoptosis and senescence: conundrum or rapalog-like gerosuppression?
Mikhail V. Blagosklonny
AGING-US (2012)
Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency
Lawrence A. Donehower
AGING-US (2012)
Answering the ultimate question What is the Proximal Cause of Aging?
Mikhail V. Blagosklonny
AGING-US (2012)
Recent discoveries in the cycling, growing and aging of the p53 field
James McCubrey et al.
AGING-US (2012)
Beyond average: potential for measurement of short telomeres
Elsa Vera et al.
AGING-US (2012)
Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice
Elena A. Komarova et al.
AGING-US (2012)
Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging
Mikhail V. Blagosklonny
AGING-US (2012)
New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/- mice by delaying carcinogenesis
Maria Comas et al.
AGING-US (2012)
Prospective Treatment of Age-Related Diseases by Slowing Down Aging
Mikhail V. Blagosklonny
AMERICAN JOURNAL OF PATHOLOGY (2012)
Dissecting the role of mTOR complexes in cellular senescence
Manuel Serrano
CELL CYCLE (2012)
A new chronological survival assay in mammalian cell culture
Matt Kaeberlein et al.
CELL CYCLE (2012)
Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
Marina Kolesnichenko et al.
CELL CYCLE (2012)
Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells
Olga V. Leontieva et al.
CELL CYCLE (2012)
Chronological and replicative lifespan in yeast: Do they meet in the middle?
Michael Polymenis et al.
CELL CYCLE (2012)
Suppression of replicative senescence by rapamycin in rodent embryonic cells
Tatiana V. Pospelova et al.
CELL CYCLE (2012)
Replicative and Chronological Aging in Saccharomyces cerevisiae
Valter D. Longo et al.
CELL METABOLISM (2012)
Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence
Cecilia A. Hinojosa et al.
EXPERIMENTAL GERONTOLOGY (2012)
Astrocyte Senescence as a Component of Alzheimer's Disease
Rekha Bhat et al.
PLOS ONE (2012)
Hypoxia suppresses conversion from proliferative arrest to cellular senescence
Olga V. Leontieva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Yuchen Jiao et al.
ONCOTARGET (2012)
Depletion of Ku70/80 reduces the levels of extrachromosomal telomeric circles and inhibits proliferation of ALT cells
Baomin Li et al.
AGING-US (2011)
Nuclear protein accumulation in cellular senescence and organismal aging revealed with a novel single-cell resolution fluorescence microscopy assay
Marco De Cecco et al.
AGING-US (2011)
Molecular damage in cancer: an argument for mTOR-driven aging
Mikhail V. Blagosklonny
AGING-US (2011)
Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression
Olga V. Leontieva et al.
AGING-US (2011)
The Werner Syndrome protein: linking the replication checkpoint response to genome stability
Pietro Pichierri et al.
AGING-US (2011)
Deciphering the role of Nuclear Factor-κB in cellular senescence
Simon Vaughan et al.
AGING-US (2011)
mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency A roadmap from energy metabolism to stem cell renewal and aging
Javier A. Menendez et al.
CELL CYCLE (2011)
mTOR signaling in disease
Eva Dazert et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Tae-Won Kang et al.
NATURE (2011)
mTOR couples cellular nutrient sensing to organismal metabolic homeostasis
Jessica J. Howell et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
Phosphorylation of AKT: a Mutational Analysis
Jonathan R. Hart et al.
ONCOTARGET (2011)
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
Olga V. Leontieva et al.
AGING-US (2010)
Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives
Mikhail V. Blagosklonny
AGING-US (2010)
The p53 inducing drug dosage may determine quiescence or senescence
David P. Lane et al.
AGING-US (2010)
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
Lioubov G. Korotchkina et al.
AGING-US (2010)
Weak p53 permits senescence during cell cycle arrest
Olga V. Leontieva et al.
CELL CYCLE (2010)
Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles
Deepak Adhikari et al.
HUMAN MOLECULAR GENETICS (2010)
Paradoxical suppression of cellular senescence by p53
Zoya N. Demidenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein
Zhaohui Feng et al.
TRENDS IN CELL BIOLOGY (2010)
Is miR-29 an Oncogene or Tumor Suppressor in CLL?
Yuri Pekarsky et al.
ONCOTARGET (2010)
DNA damage response and cellular senescence in tissues of aging mice
Chunfang Wang et al.
AGING CELL (2009)
Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density
Yong Pan et al.
AGING-US (2009)
Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential
Zoya N. Demidenko et al.
AGING-US (2009)
Growth and aging: a common molecular mechanism
Mikhail V. Blagosklonny et al.
AGING-US (2009)
Validation of anti-aging drugs by treating age-related diseases
Mikhail V. Blagosklonny
AGING-US (2009)
Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence
Zoya N. Demidenko et al.
CELL CYCLE (2009)
mTORC1 signaling governs hematopoietic stem cell quiescence
Boyi Gan et al.
CELL CYCLE (2009)
Rapamycin decelerates cellular senescence
Zoya N. Demidenko et al.
CELL CYCLE (2009)
mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging
Rogerio M. Castilho et al.
CELL STEM CELL (2009)
Tor1/Sch9-Regulated Carbon Source Substitution Is as Effective as Calorie Restriction in Life Span Extension
Min Wei et al.
PLOS GENETICS (2009)
Growth stimulation leads to cellular senescence when the cell cycle is blocked
Zoya N. Demidenko et al.
CELL CYCLE (2008)
Aging, stem cells, and mammalian target of rapamycin: A prospect of pharmacologic rejuvenation of aging stem cells
Mikhail V. Blagosklonny
REJUVENATION RESEARCH (2008)
An anti-aging drug today: from senescence-promoting genes to anti-aging pill
Mikhail V. Blagosklonny
DRUG DISCOVERY TODAY (2007)
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase
J. Avruch et al.
ONCOGENE (2006)
Increased cell-to-cell variation in gene expression in ageing mouse heart
Rumana Bahar et al.
NATURE (2006)
Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways
AJ Levine et al.
GENES & DEVELOPMENT (2006)
Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients
M Kaeberlein et al.
SCIENCE (2005)
Inhibition of phosphatidylinostol 3-kinase uncouples H2O2-induced senescent phenotype and cell cycle arrest in normal human diploid fibroblasts
Y Wang et al.
EXPERIMENTAL CELL RESEARCH (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Mechanisms of cellular senescence in human and mouse cells
K Itahana et al.
BIOGERONTOLOGY (2004)
Reversal of human cellular senescence:: roles of the p53 and p16 pathways
CM Beauséjour et al.
EMBO JOURNAL (2003)
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
S Parrinello et al.
NATURE CELL BIOLOGY (2003)
Reversal of senescence in mouse fibroblasts through lentiviral in suppression of p53
AMG Dirac et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cell senescence and hypermitogenic arrest
MV Blagosklonny
EMBO REPORTS (2003)
Oncogenic ras and p53 cooperate to induce cellular senescence
G Ferbeyre et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Regulation of cellular senescence by p53
K Itahana et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Lack of replicative senescence in cultured rat - Oligodendrocyte precursor cells
DG Tang et al.
SCIENCE (2001)
Escape from premature senescence is not sufficient for oncogenic transformation by Ras
DS Peeper et al.
NATURE CELL BIOLOGY (2001)
Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts
V Dulic et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
